Domain ID,Annotation,Annotation Members in Network,Annotation Members in Network Count,Summed Significance Score,Enrichment P-value,Enrichment Q-value,Depletion P-value,Depletion Q-value
1,copper ion import,FRE1;FRE4,2,28.77528010406445,0.004,1.0,0.996,1.0
1,cell wall (1->3)-beta-D-glucan biosynthetic process,GAS1;GAS3;GAS5,3,26.387640052032225,0.001,0.351,1.0,1.0
1,cell wall beta-glucan biosynthetic process,GAS1;GAS3;GAS5;KAR2,4,26.387640052032225,0.001,0.351,1.0,1.0
1,fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process,GAS1;GAS3;GAS5,3,26.387640052032225,0.001,0.351,1.0,1.0
1,fungal-type cell wall beta-glucan biosynthetic process,GAS1;GAS3;GAS5;KAR2,4,26.387640052032225,0.001,0.351,1.0,1.0
1,copper ion transport,CCC2;FRE1;FRE4;QDR2,4,25.162920156096675,0.008,1.0,0.996,1.0
1,regulation of dephosphorylation,IST2;SCS2,2,23.049825047428502,0.012,1.0,0.992,1.0
1,regulation of phosphatidylinositol dephosphorylation,IST2;SCS2,2,23.049825047428502,0.012,1.0,0.992,1.0
1,cell wall polysaccharide biosynthetic process,FKS1;GAS1;GAS3;GAS5;GSC2;KAR2;MNN5,7,22.13202028617724,0.008,1.0,1.0,1.0
1,proton export across plasma membrane,PMA1;PMA2,2,21.550560208128903,0.016,1.0,1.0,1.0
1,regulation of phospholipid metabolic process,GTS1;IST2;NTE1;SCS2,4,21.550560208128903,0.016,1.0,0.992,1.0
1,mannose transmembrane transport,HXT1;HXT2;HXT5,3,20.387640052032225,0.02,1.0,0.992,1.0
1,glucan catabolic process,CDC28;EXG2;GDB1;GPH1,4,17.93820026016113,0.032,1.0,0.992,1.0
1,phosphatidylinositol dephosphorylation,INP51;INP53;IST2;SCS2,4,17.93820026016113,0.032,1.0,0.992,1.0
1,phospholipid dephosphorylation,INP51;INP53;IST2;SCS2,4,17.93820026016113,0.032,1.0,0.992,1.0
1,polysaccharide catabolic process,CDC28;DSE4;EXG2;GDB1;GPH1,5,17.93820026016113,0.032,1.0,0.992,1.0
1,xenobiotic transport,PDR15;PDR5;QDR2;SNQ2;YOR1,5,17.93820026016113,0.032,1.0,0.992,1.0
1,export across plasma membrane,PDR15;PDR5;PMA1;PMA2;QDR2;SAP185;SNQ2,7,16.77528010406445,0.04,1.0,0.992,1.0
1,amino sugar metabolic process,BCH1;BMH1;BMH2;CHS3;CHS5;CRH1;UTR2,7,16.27856788216575,0.044,1.0,0.992,1.0
1,aminoglycan metabolic process,BCH1;BMH1;BMH2;CHS3;CHS5;CRH1;UTR2,7,16.27856788216575,0.044,1.0,0.992,1.0
1,cell wall chitin metabolic process,BCH1;BMH1;BMH2;CHS3;CHS5;CRH1;UTR2,7,16.27856788216575,0.044,1.0,0.992,1.0
1,glucosamine-containing compound metabolic process,BCH1;BMH1;BMH2;CHS3;CHS5;CRH1;UTR2,7,16.27856788216575,0.044,1.0,0.992,1.0
1,iron ion transport,AIM14;ENB1;FRE1;FRE4;PET9;SIT1;SMF3;TDH3,8,15.82510515149295,0.048,1.0,0.988,1.0
2,protein sumoylation,KRE29;NSE3;SMC5;SMC6,4,33.0,0.001,0.20057142857142857,0.996,1.0
2,vesicle coating,GLO3;SEC16;SEC23;SEC28,4,33.0,0.001,0.20057142857142857,0.996,1.0
2,phosphatidic acid biosynthetic process,AYR1;SLC1,2,27.129006293476124,0.001,1.0,1.0,1.0
2,regulation of DNA double-strand break processing,DPB4;RTT107,2,21.129006293476127,0.012,1.0,0.996,1.0
2,resolution of DNA recombination intermediates,SMC5;SMC6,2,21.129006293476127,0.012,1.0,0.996,1.0
2,"vesicle targeting, to, from or within Golgi",GLO3;SEC16;SEC23,3,21.129006293476127,0.012,1.0,0.996,1.0
2,triglyceride metabolic process,AYR1;CDC28;GPT2;SAH1;TGL4;YJU3,6,20.676552508903914,0.004,1.0,1.0,1.0
2,acylglycerol metabolic process,AYR1;CDC28;CMR2;GPT2;SAH1;TGL4;YJU3,7,20.07449251757595,0.008,1.0,1.0,1.0
2,neutral lipid metabolic process,AYR1;CDC28;CMR2;GPT2;SAH1;TGL4;YJU3,7,20.07449251757595,0.008,1.0,1.0,1.0
2,DNA double-strand break attachment to nuclear envelope,RTT107;SMC6,2,19.75468019078483,0.016,1.0,1.0,1.0
2,chromosome attachment to the nuclear envelope,RTT107;SMC6,2,19.75468019078483,0.016,1.0,1.0,1.0
2,Golgi inheritance,RET2;SEC8,2,18.688670047696206,0.02,1.0,1.0,1.0
2,acylglycerol catabolic process,AYR1;CDC28;TGL4;YJU3,4,18.688670047696206,0.02,1.0,1.0,1.0
2,neutral lipid catabolic process,AYR1;CDC28;TGL4;YJU3,4,18.688670047696206,0.02,1.0,1.0,1.0
2,regulation of DNA damage checkpoint,CDC28;CMR1;RTT107,3,18.688670047696206,0.02,1.0,0.996,1.0
2,triglyceride catabolic process,AYR1;CDC28;TGL4;YJU3,4,18.688670047696206,0.02,1.0,1.0,1.0
2,glycerolipid catabolic process,AYR1;CDC28;GDE1;NTE1;PGC1;PLB1;TGL4;YJU3,8,15.377340095392412,0.04,1.0,0.996,1.0
2,signal transduction in response to DNA damage,BMH1;BMH2;BRE1;CDC28;CMR1;FAR11;GLC7;LCD1;POL2;RTT107;TSA1,11,14.506346388868538,0.048,1.0,0.996,1.0
3,negative regulation of mRNA catabolic process,ATP25;NAB2,2,72.06649614590118,0.016,1.0,1.0,1.0
3,negative regulation of translational initiation,AAT2;MPT5;PAT1;TIF5,4,29.012692777737076,0.048,1.0,1.0,1.0
4,RNA import into nucleus,RIO2;RNA1;SIS1;SSA2;YDJ1,5,27.0,0.001,0.10028571428571428,0.972,1.0
4,tRNA import into nucleus,SIS1;SSA2;YDJ1,3,27.0,0.001,0.10028571428571428,0.98,1.0
4,stress granule disassembly,HSP104;SBP1;SSA1,3,19.975577717920025,0.001,0.1755,0.992,1.0
4,sulfur compound transport,MUP3;OAC1;VHT1,3,17.287368785571378,0.012,0.67392,0.992,1.0
4,protein insertion into ER membrane,BFR1;HSP104;MDY2;SGT2;YDJ1,5,16.423097585953087,0.012,1.0,0.992,1.0
4,nuclear protein quality control by the ubiquitin-proteasome system,CDC48;SIS1,2,16.16292015609668,0.016,0.7746206896551725,0.988,1.0
4,protein-RNA complex disassembly,DED1;HSP104;NTR2;PRP43;SBP1;SSA1,6,15.710466371524463,0.012,1.0,0.992,1.0
4,Golgi to plasma membrane protein transport,ARL1;COF1;SEC18,3,14.578098824595545,0.024,0.9107027027027027,0.992,1.0
4,response to salt stress,ALD6;HSP42;MYO5;NST1;SIS2;TCO89,6,13.96573887662777,0.008,1.0,0.984,1.0
4,dicarboxylic acid transport,BPT1;OAC1;TNA1;YCF1;YHM2,5,13.453650195120845,0.032,1.0,0.98,1.0
4,monocarboxylic acid transport,ADY2;ATO2;FAA4;OAC1;VHT1;YBT1,6,13.453650195120845,0.032,1.0,0.988,1.0
4,cell redox homeostasis,AHP1;MRPL51;PMD1;POR1;SEN1;TRR1;TRX1;TRX2;TSA1;YCF1,10,12.993277493094412,0.036,1.0,0.956,1.0
7,intracellular mRNA localization,BFR1;COP1;LOC1;MPT5;NUP60;SEC26;SEC27;SPT4;SPT5;SSD1,10,104.93820026016112,0.004,0.624,1.0,1.0
7,'de novo' pyrimidine nucleobase biosynthetic process,CPA2;URA4;URA6,3,90.0,0.001,0.2808,1.0,1.0
7,vitamin B6 metabolic process,BUD17;PDX3;YBL036C,3,90.0,0.001,0.2808,1.0,1.0
7,positive regulation of transmembrane transport,RGC1;SAP185,2,50.96910013008056,0.02,1.0,1.0,1.0
7,glutamine family amino acid catabolic process,CAR1;PUT2,2,48.593662748651816,0.024,1.0,1.0,1.0
7,arginine metabolic process,CAR1;CPA2,2,44.84550065040282,0.032,1.0,1.0,1.0
7,aromatic amino acid family biosynthetic process,ARO3;TRP5,2,44.84550065040282,0.032,1.0,1.0,1.0
7,nitrogen cycle metabolic process,CAR1;URE2,2,44.84550065040282,0.032,1.0,1.0,1.0
7,pyrimidine ribonucleoside monophosphate biosynthetic process,URA4;URK1,2,44.84550065040282,0.032,1.0,1.0,1.0
7,pyridoxal 5'-phosphate salvage,BUD17;PDX3,2,41.938200260161125,0.04,1.0,1.0,1.0
7,pyridoxal phosphate biosynthetic process,BUD17;PDX3,2,41.938200260161125,0.04,1.0,1.0,1.0
7,vitamin B6 biosynthetic process,BUD17;PDX3,2,41.938200260161125,0.04,1.0,1.0,1.0
7,NADH oxidation,ADH3;GPD1;NDI1,3,40.69641970541439,0.044,1.0,0.996,1.0
7,positive regulation of RNA binding,MPT5;SNU13;YHC1,3,39.56276287873238,0.048,1.0,0.992,1.0
8,mitochondrial DNA replication,MHR1;RIM1,2,76.41106517897198,0.024,1.0,1.0,1.0
8,positive regulation of mitochondrial DNA metabolic process,MHR1;RIM1,2,76.41106517897198,0.024,1.0,1.0,1.0
8,mitochondrial DNA metabolic process,MHR1;PIM1;RIM1,3,70.16412834855699,0.032,1.0,1.0,1.0
8,regulation of mitochondrial DNA metabolic process,MHR1;PIM1;RIM1,3,70.16412834855699,0.032,1.0,1.0,1.0
9,acetate biosynthetic process,ALD4;ALD5;ALD6,3,96.8721901170725,0.001,0.0468,1.0,1.0
9,acetate metabolic process,ALD4;ALD5;ALD6,3,96.8721901170725,0.001,0.0468,1.0,1.0
9,ethanol metabolic process,ALD4;ALD5;ALD6;PDC1,4,94.16292015609667,0.001,0.0468,1.0,1.0
9,primary alcohol metabolic process,ALD4;ALD5;ALD6;PDC1,4,94.16292015609667,0.001,0.0468,1.0,1.0
9,serine family amino acid catabolic process,CHA1;ILV1;LPD1;SHM1;SHM2,5,90.30524039891372,0.004,0.14400000000000002,1.0,1.0
9,2-oxoglutarate metabolic process,KGD1;KGD2;LPD1,3,78.0,0.001,0.0468,1.0,1.0
9,acetyl-CoA biosynthetic process,LAT1;LPD1;PDA1;PDB1;PDX1,5,78.0,0.001,0.0468,1.0,1.0
9,acetyl-CoA metabolic process,KGD2;LAT1;LPD1;PDA1;PDB1;PDX1,6,78.0,0.001,0.0468,1.0,1.0
9,alpha-amino acid catabolic process,ALT1;BNA4;CAR1;CHA1;EHD3;GLY1;ILV1;KGD2;LPD1;PDC1;PUT2;SAH1;SHM1;SHM2,14,78.0,0.001,0.0468,1.0,1.0
9,dicarboxylic acid biosynthetic process,AAT2;ARO3;BNA4;FOL2;GDH1;IDH1;IDH2;IDP1;MIS1;PUT2,10,78.0,0.001,0.0468,1.0,1.0
9,dicarboxylic acid metabolic process,AAT2;ARO3;BNA4;FOL2;FUM1;GDH1;HOM3;IDH1;IDH2;IDP1;KGD1;KGD2;LPD1;MDH1;MDH2;MIS1;PCS60;PUT2;SHM1;SHM2,20,78.0,0.001,0.0468,1.0,1.0
9,glutamate biosynthetic process,GDH1;IDH1;IDH2;IDP1;PUT2,5,78.0,0.001,0.0468,1.0,1.0
9,glutamate metabolic process,GDH1;IDH1;IDH2;IDP1;PUT2,5,78.0,0.001,0.0468,1.0,1.0
9,purine nucleoside bisphosphate biosynthetic process,CAB3;LAT1;LPD1;PDA1;PDB1;PDX1;SIS2,7,78.0,0.001,0.0468,1.0,1.0
9,thioester biosynthetic process,LAT1;LPD1;PDA1;PDB1;PDX1,5,78.0,0.001,0.0468,1.0,1.0
9,thioester metabolic process,FAA3;FAA4;KGD2;LAT1;LPD1;LSC1;LSC2;PDA1;PDB1;PDX1;TES1,11,78.0,0.001,0.0468,1.0,1.0
9,tricarboxylic acid cycle,ACO1;FUM1;IDH1;IDH2;IDP1;KGD1;KGD2;LSC1;LSC2;LYS12;MDH1;MDH2;MLS1;SDH1;SDH2,15,78.0,0.001,0.0468,1.0,1.0
9,ubiquinone biosynthetic process,CAT5;COQ3;COQ5,3,78.0,0.001,0.0468,1.0,1.0
9,valine metabolic process,BAT1;BAT2;EHD3;ILV2;ILV3;ILV5;ILV6;LPD1,8,78.0,0.001,0.0468,1.0,1.0
9,L-serine metabolic process,CHA1;CYS4;ILV1;LPD1;MCY1;SER2;SHM1;SHM2,8,76.31646285525001,0.012,0.3918139534883721,1.0,1.0
9,ethanol catabolic process,ALD5;ALD6,2,63.045410229808994,0.02,0.585,1.0,1.0
9,primary alcohol catabolic process,ALD5;ALD6,2,63.045410229808994,0.02,0.585,1.0,1.0
9,aspartate family amino acid catabolic process,CHA1;GLY1;ILV1;KGD2,4,62.346440225472975,0.004,0.14400000000000002,1.0,1.0
9,branched-chain amino acid catabolic process,BAT1;BAT2;EHD3;LPD1;PDC1,5,62.346440225472975,0.004,0.14400000000000002,1.0,1.0
9,leucine metabolic process,BAT1;BAT2;LEU4;LPD1,4,62.346440225472975,0.004,0.14400000000000002,1.0,1.0
9,protein maturation by [2Fe-2S] cluster transfer,GRX5;SSQ1,2,62.346440225472975,0.004,0.14400000000000002,1.0,1.0
9,protein maturation by iron-sulfur cluster transfer,GRX5;SSQ1,2,62.346440225472975,0.004,0.14400000000000002,1.0,1.0
9,L-serine biosynthetic process,LPD1;SER2,2,44.17322011273649,0.02,0.585,1.0,1.0
9,fatty acid beta-oxidation using acyl-CoA dehydrogenase,AIM45;CIR1,2,38.866100563682444,0.032,0.702,1.0,1.0
9,valine catabolic process,EHD3;LPD1,2,36.346440225472975,0.04,0.78,1.0,1.0
9,amide catabolic process,DAL82;KGD2;PUT2,3,35.27023041135913,0.044,0.792,1.0,1.0
12,polyadenylation-dependent snoRNA 3'-end processing,LRP1;MTR3;MTR4;RRP4;RRP40;RRP46;RRP6;SKI6,8,79.45365019512084,0.001,0.052,0.98,1.0
12,U5 snRNA 3'-end processing,LRP1;MTR4;RRP42;RRP43;RRP45;RRP6;SKI6,7,75.85159020379288,0.001,0.052,0.992,1.0
12,nuclear polyadenylation-dependent rRNA catabolic process,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6,15,69.17392641615152,0.001,0.052,0.968,1.0
12,U4 snRNA 3'-end processing,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11,68.03511027316918,0.001,0.052,0.98,1.0
12,snRNA 3'-end processing,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11,68.03511027316918,0.001,0.052,0.98,1.0
12,snRNA processing,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SEN1;SKI6,12,67.68292775505782,0.001,0.052,0.98,1.0
12,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,14,64.68937635111124,0.001,0.052,0.972,1.0
12,nuclear polyadenylation-dependent ncRNA catabolic process,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16,64.68937635111124,0.001,0.052,0.968,1.0
12,nuclear polyadenylation-dependent tRNA catabolic process,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,13,64.68937635111124,0.001,0.052,0.968,1.0
12,polyadenylation-dependent RNA catabolic process,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16,64.68937635111124,0.001,0.052,0.968,1.0
12,tRNA catabolic process,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;XRN1,14,64.68937635111124,0.001,0.052,0.968,1.0
12,RNA surveillance,AIR2;CSL4;DIS3;DOM34;GBP2;LRP1;MLP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;SUS1,20,62.31554035555354,0.001,0.052,0.964,1.0
12,nuclear RNA surveillance,AIR2;CSL4;DIS3;GBP2;LRP1;MLP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;SUS1,19,62.31554035555354,0.001,0.052,0.964,1.0
12,snRNA metabolic process,AIR2;BDF1;CBF5;GAR1;LRP1;MTR3;MTR4;NHP2;NOP10;PRP16;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SEN1;SKI6,19,59.872190117072506,0.001,0.052,0.968,1.0
12,nuclear polyadenylation-dependent CUT catabolic process,AIR2;DIS3;LRP1;MPP6;MTR3;RRP6;SKI6,7,55.53685540861959,0.001,0.052,0.996,1.0
12,nuclear mRNA surveillance of mRNA 3'-end processing,AIR2;MPP6;MTR4,3,47.646980114003355,0.012,0.5809655172413793,0.992,1.0
12,U1 snRNA 3'-end processing,RRP42;RRP43;RRP45;RRP6;SKI6,5,44.15173924215486,0.004,1.0,0.996,1.0
13,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BUD21;BUD23;DBP8;DIP2;EMG1;ENP1;ESF2;FCF1;FCF2;KRR1;LCP5;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;ROK1;RPS0A;RPS0B;RPS18A;RPS18B;RPS21A;RPS21B;RRP5;RRP9;RRS1;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,41,122.0308849772965,0.008,1.0,0.932,1.0
13,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BMS1;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LCP5;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PWP2;RCL1;ROK1;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,30,76.57993404571604,0.004,1.0,0.968,1.0
13,"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BMS1;BUD21;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;ROK1;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,31,64.72412758161707,0.024,1.0,0.968,1.0
13,rRNA 5'-end processing,BMS1;BRX1;BUD21;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PNO1;PWP2;RCL1;RLP7;ROK1;RRP17;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,34,64.47425010840047,0.032,1.0,0.964,1.0
13,box C/D RNA 3'-end processing,NOP1;PXR1,2,39.84129024715307,1.0,1.0,0.996,1.0
13,small-subunit processome assembly,ESF2;MRD1,2,36.49555632509513,1.0,1.0,0.992,1.0
13,nuclear polyadenylation-dependent snoRNA catabolic process,AIR2;RRP6,2,32.280430082384356,1.0,1.0,0.996,1.0
14,proton motive force-driven ATP synthesis,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;TIM11;VMA1,16,122.15758633090317,0.004,0.312,0.996,1.0
14,aerobic electron transport chain,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18,114.0,0.001,0.08775,0.888,1.0
14,cyclic threonylcarbamoyladenosine biosynthetic process,TCD1;TCD2,2,114.0,0.001,0.08775,0.992,1.0
14,mitochondrial ATP synthesis coupled electron transport,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18,114.0,0.001,0.08775,0.888,1.0
14,"mitochondrial electron transport, cytochrome c to oxygen",COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8,8,114.0,0.001,0.08775,0.948,1.0
14,"mitochondrial electron transport, ubiquinol to cytochrome c",CYT1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1,8,114.0,0.001,0.08775,0.952,1.0
14,mitochondrial protein processing,AFG3;COR1;CYM1;YTA12,4,114.0,0.001,0.08775,0.976,1.0
14,mitochondrial respiratory chain complex III assembly,QCR7;QCR9,2,114.0,0.001,0.08775,0.996,1.0
14,oxidative phosphorylation,ATP15;ATP2;ATP5;COX1;COX12;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,22,114.0,0.001,0.08775,0.884,1.0
14,respiratory electron transport chain,CIR2;COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1;SDH2,20,114.0,0.001,0.08775,0.872,1.0
14,purine ribonucleoside triphosphate biosynthetic process,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;IMD3;IMD4;TIM11;VMA1;YNK1,19,107.40711654336809,0.008,0.48834782608695654,0.992,1.0
14,positive regulation of establishment of protein localization,ALY2;POR1,2,54.860504970843074,0.036,1.0,0.988,1.0
14,lactate metabolic process,DLD1;DLD3,2,53.121720329537425,0.04,1.0,0.996,1.0
14,cysteine biosynthetic process from serine,CYS4;MCY1,2,51.54879829352492,0.044,1.0,0.988,1.0
14,regulation of protein import into nucleus,POR1;SCS2,2,50.11283297972768,0.048,1.0,0.984,1.0
16,rRNA 3'-end processing,CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RPS0A;RPS0B;RPS21A;RPS21B;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;TSR1,19,158.31554035555354,0.001,0.2808,1.0,1.0
16,"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",RPS0A;RPS0B;RPS21A;RPS21B;TSR1,5,113.32436999079255,0.001,0.2808,1.0,1.0
18,response to arsenic-containing substance,CUZ1;MET30;MET4;TIM18,4,91.97557771792003,0.001,0.1755,0.984,1.0
18,translational frameshifting,ANB1;ASC1;HYP2;SSB1;SSB2;SSZ1;ZUO1,7,88.72378032086539,0.004,0.46799999999999997,0.984,1.0
18,amino acid activation,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21,78.0,0.001,0.1755,0.972,1.0
18,aminoacyl-tRNA metabolism involved in translational fidelity,CDC60;ILS1;NAM2;VAS1;YHR020W,5,78.0,0.001,0.1755,1.0,1.0
18,protein insertion into mitochondrial inner membrane,OXA1;TIM18;TIM54;TOM70,4,78.0,0.001,0.1755,0.988,1.0
18,tRNA aminoacylation for protein translation,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21,78.0,0.001,0.1755,0.972,1.0
18,positive regulation of protein-containing complex disassembly,ANB1;HYP2;TWF1,3,62.346440225472975,0.004,0.46799999999999997,0.992,1.0
18,positive regulation of translational elongation,ANB1;EFT1;EFT2;HYP2,4,62.346440225472975,0.004,0.46799999999999997,0.992,1.0
18,positive regulation of translational termination,ANB1;HYP2,2,62.346440225472975,0.004,0.46799999999999997,0.992,1.0
18,regulation of translational termination,ANB1;CAM1;ECM32;EFB1;HYP2;NEW1,6,54.51966033820946,0.008,0.7488,0.98,1.0
18,cytoplasmic microtubule organization,NUD1;SPC98,2,40.3738911851023,0.028,1.0,0.996,1.0
18,monosaccharide catabolic process,PFK1;PFK2;RBK1,3,38.866100563682444,0.032,1.0,0.992,1.0
18,microtubule nucleation,SPC110;SPC98,2,38.74438023414501,0.004,0.8022857142857143,1.0,1.0
18,tRNA aminoacylation for mitochondrial protein translation,GRS1;MSK1;SLM5,3,37.53613498005053,0.036,1.0,0.984,1.0
18,mitochondrion-endoplasmic reticulum membrane tethering,MDM10;MMM1;NVJ2,3,36.346440225472975,0.04,1.0,1.0,1.0
18,spindle assembly,CDC28;KIP1;NUD1;SPC98,4,35.27023041135913,0.044,1.0,0.996,1.0
18,RNA (guanine-N7)-methylation,BUD23;TRM112;TRM8,3,34.28772782823473,0.048,1.0,1.0,1.0
18,iron ion transmembrane transport,ENB1;SIT1,2,34.28772782823473,0.048,1.0,0.996,1.0
19,regulation of translational fidelity,CDC60;GCD11;ILS1;NAM2;RPL31A;RPL31B;RPS2;RPS23A;RPS23B;RPS5;RPS9B;SSB1;SSB2;SSZ1;SUI1;VAS1;YHR020W;ZUO1,18,172.1584594058181,0.001,0.20057142857142857,1.0,1.0
20,response to alcohol,PDR5;RPL42A;RPL42B,3,19.75468019078483,0.016,1.0,1.0,1.0
20,response to cycloheximide,PDR5;RPL42A;RPL42B,3,19.75468019078483,0.016,1.0,1.0,1.0
20,response to antibiotic,PBS2;PDR5;RPL42A;RPL42B,4,15.880672491559837,0.036,1.0,1.0,1.0
22,maintenance of translational fidelity,ASC1;EFB1;EFT1;EFT2;RPL2A;RPL3;RPS12;RPS3;RPS31;SUI1,10,114.0,0.001,0.1755,1.0,1.0
22,N-terminal protein amino acid acetylation,ARD1;MDM20;NAT1;NAT5,4,81.0,0.001,0.1755,1.0,1.0
22,N-terminal protein amino acid modification,ARD1;MDM20;NAT1;NAT5,4,81.0,0.001,0.1755,1.0,1.0
22,protein acetylation,ADA2;ARD1;MDM20;NAT1;NAT5,5,81.0,0.001,0.1755,1.0,1.0
22,protein acylation,ADA2;AKR1;ARD1;MDM20;NAT1;NAT5,6,81.0,0.001,0.1755,1.0,1.0
22,G protein-coupled receptor signaling pathway,ASC1;IRA1,2,45.872190117072506,0.02,1.0,1.0,1.0
22,negative regulation of translational elongation,ASC1;DHH1,2,37.74438023414501,0.04,1.0,1.0,1.0
22,glucose mediated signaling pathway,ASC1;GPB2;YCK1,3,36.626777734872945,0.044,1.0,1.0,1.0
23,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,ELP3;IKI3,2,42.0,0.001,0.46799999999999997,1.0,1.0
23,folic acid biosynthetic process,FOL2;MIS1,2,21.73978756120893,0.028,1.0,1.0,1.0
23,folic acid-containing compound biosynthetic process,FOL2;MIS1;MTD1,3,20.927900303521316,0.032,1.0,1.0,1.0
23,cellular modified amino acid biosynthetic process,AIM17;FOL2;MIS1;MTD1,4,20.211764989257976,0.036,1.0,1.0,1.0
23,pteridine-containing compound biosynthetic process,FOL2;MCO14;MIS1;MTD1,4,19.571160121408525,0.04,1.0,1.0,1.0
24,folic acid metabolic process,FOL2;MIS1;SHM1;SHM2,4,46.95046270263414,0.04,1.0,1.0,1.0
24,regulation of double-strand break repair,BDF1;CDC28;HHO1,3,33.979400086720375,0.02,1.0,1.0,1.0
24,glycine biosynthetic process,GLY1;SHM1;SHM2,3,31.056839373155615,0.028,1.0,1.0,1.0
24,glycine metabolic process,GLY1;LPD1;SHM1;SHM2,4,29.897000433601878,0.032,1.0,1.0,1.0
24,L-serine catabolic process,CHA1;ILV1;SHM1;SHM2,4,28.87394998465425,0.036,1.0,1.0,1.0
24,cytoplasmic translational elongation,HYP2;RPP2A;RPP2B;RQC2,4,27.95880017344075,0.04,1.0,1.0,1.0
24,tetrahydrofolate interconversion,ADE3;MET13;MIS1;SHM1;SHM2,5,27.130946470276246,0.044,1.0,1.0,1.0
25,regulation of ribosomal subunit export from nucleus,NOG2;REA1,2,27.581460078048337,0.001,1.0,1.0,1.0
25,regulation of ribonucleoprotein complex localization,NOG2;PPH22;REA1,3,24.571160121408525,0.004,1.0,1.0,1.0
25,ribonucleoprotein complex localization,NOG2;PPH22;REA1,3,24.571160121408525,0.004,1.0,1.0,1.0
28,assembly of large subunit precursor of preribosome,DBP10;NIP7;NOG1;NOP2;RLP24;RPF2;SPB4;TIF6,8,147.0,0.001,0.2808,1.0,1.0
28,"exonucleolytic trimming to generate mature 5'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BRX1;RLP7,2,88.79574895287382,0.012,1.0,1.0,1.0
30,ribosomal large subunit assembly,BRX1;DRS1;IPI1;IPI3;LSG1;MAK11;MAK21;MRH4;MRT4;NOP53;REA1;REX4;RIX1;RPF2;RPL10;RPL11A;RPL11B;RPL12A;RPL12B;RPL14A;RPL14B;RPL25;RPL3;RPL33A;RPL40A;RPL40B;RPL5;RPL6A;RPL6B;RPP0;RRP5;RSA3;RSA4;SPB4;SQT1;SSF1;SSF2;YVH1,38,332.7937151744399,0.001,0.46799999999999997,1.0,1.0
31,positive regulation of DNA binding,SPT6;SUA7,2,14.387640052032225,0.004,0.5105454545454545,1.0,1.0
31,carbon catabolite repression of transcription,SPT6;TUP1;VPS36,3,12.581460078048337,0.008,0.5616,1.0,1.0
31,carbon catabolite repression of transcription from RNA polymerase II promoter by glucose,SPT6;TUP1;VPS36,3,12.581460078048337,0.008,0.5616,1.0,1.0
31,catabolite repression,SPT6;TUP1;VPS36,3,12.581460078048337,0.008,0.5616,1.0,1.0
31,regulation of transcription from RNA polymerase II promoter by glucose,SPT6;TUP1;VPS36,3,12.581460078048337,0.008,0.5616,1.0,1.0
31,regulation of transcriptional start site selection at RNA polymerase II promoter,CHD1;ISW1;SPT6,3,12.581460078048337,0.008,0.5616,1.0,1.0
31,transcription elongation-coupled chromatin remodeling,HIR2;SPT5,2,12.581460078048337,0.008,0.5616,1.0,1.0
31,regulation of DNA replication origin binding,CDC28;SPT6,2,11.524912523714251,0.012,0.7658181818181817,1.0,1.0
31,positive regulation of binding,MPT5;SNU13;SPT6;SUA7;YHC1,5,10.775280104064452,0.016,0.8640000000000001,1.0,1.0
31,regulation of DNA binding,CDC28;GRX3;SBA1;SPT6;SUA7,5,9.317051811946685,0.028,1.0,1.0,1.0
31,regulation of nucleotide-excision repair,CDC73;CTR9;LEO1;PAF1;RTF1;SPT4;SPT5,7,9.317051811946685,0.028,1.0,1.0,1.0
31,regulation of transcription-coupled nucleotide-excision repair,CDC73;CTR9;LEO1;PAF1;RTF1;SPT4;SPT5,7,9.317051811946685,0.028,1.0,1.0,1.0
31,regulation of rRNA processing,CCM1;NAN1;RIO1;SPT4;SPT5,5,8.969100130080564,0.032,1.0,1.0,1.0
31,regulation of binding,CDC28;GRX3;MPT5;SBA1;SNU13;SPT6;SUA7;YHC1,8,8.662184995396276,0.036,1.0,0.996,1.0
31,regulation of DNA repair,BDF1;CDC28;CDC73;CTR9;HHO1;LEO1;PAF1;RTF1;SPT4;SPT5,10,8.139283941082875,0.044,1.0,0.996,1.0
32,rRNA transcription,BUD27;CDC73;CTR9;HHT1;HHT2;HPR1;LEO1;MOT1;PAF1;RPA12;RPA135;RPA14;RPA190;RPA34;RPA43;RPA49;RRN10;RRN9;RSC9;RTF1;SPT15;SPT4;SPT5;TFC1;TFC3;TFC4;TFC6;TFC8;TOP2,29,218.9176003468815,0.001,0.12763636363636363,1.0,1.0
32,tRNA transcription by RNA polymerase III,BUD27;RET1;RPB10;RPB5;RPB8;RPC10;RPC11;RPC17;RPC19;RPC25;RPC31;RPC34;RPC37;RPC40;RPC53;RPC82;RPO26;RPO31,18,141.0,0.001,0.12763636363636363,1.0,1.0
32,transcription by RNA polymerase III,BDP1;BRF1;BUD27;CKA1;CKA2;CKB1;CKB2;GTR1;HIR1;HIR2;MAF1;NAB2;PAF1;RET1;RPB10;RPB5;RPB8;RPC10;RPC11;RPC17;RPC19;RPC25;RPC31;RPC34;RPC37;RPC40;RPC53;RPC82;RPO26;RPO31;SEN1;SPT15;TFC1;TFC3;TFC4;TFC6;TFC8,37,141.0,0.001,0.12763636363636363,1.0,1.0
32,RNA polymerase III preinitiation complex assembly,BDP1;BRF1;SPT15,3,123.0,0.001,0.12763636363636363,1.0,1.0
32,negative regulation of DNA recombination,CDC73;HHO1;HST1;PAF1;RPD3;SET2;SIR2,7,123.0,0.001,0.12763636363636363,1.0,1.0
32,nucleolar large rRNA transcription by RNA polymerase I,BUD27;CDC73;CTR9;HPR1;LEO1;MOT1;PAF1;RPA12;RPA135;RPA14;RPA190;RPA34;RPA43;RPA49;RRN10;RRN9;RTF1;SPT15;SPT4;SPT5,20,123.0,0.001,0.12763636363636363,1.0,1.0
32,transcription elongation by RNA polymerase I,BUD27;CDC73;CTR9;HPR1;LEO1;PAF1;RPA34;RPA49;RTF1;SPT4;SPT5,11,123.0,0.001,0.12763636363636363,1.0,1.0
32,transcription initiation at RNA polymerase III promoter,BDP1;BRF1;RPC17;RPC25;RPC31;SPT15;TFC1;TFC3,8,123.0,0.001,0.12763636363636363,1.0,1.0
32,positive regulation of transcription elongation by RNA polymerase I,BUD27;CDC73;CTR9;HPR1;LEO1;PAF1;RTF1;SPT4;SPT5,9,87.1412089640796,0.012,1.0,1.0,1.0
32,"negative regulation of DNA-templated transcription, elongation",SPT4;SPT5,2,76.24798079301739,0.028,1.0,1.0,1.0
32,termination of RNA polymerase III transcription,RPC11;SEN1,2,69.89700043360187,0.04,1.0,1.0,1.0
32,RNA polymerase I preinitiation complex assembly,RPA49;SPT15,2,55.618440264066365,0.044,1.0,1.0,1.0
32,transcription initiation at RNA polymerase I promoter,RPA49;SPT15,2,55.618440264066365,0.044,1.0,1.0,1.0
33,nucleosome assembly,ASF1;FPR3;FPR4;HHF1;HHF2;HHO1;NAP1;SPN1;SPT16;SPT6,10,188.33614026883316,0.001,0.156,0.972,1.0
33,nucleosome organization,ARP7;ARP9;ASF1;CHD1;FPR3;FPR4;HHF1;HHF2;HHO1;HTL1;LDB7;NAP1;NPL6;ORC1;RSC1;RSC2;RSC3;RSC30;RSC4;RSC58;RSC6;RSC8;RSC9;RTT102;SFH1;SPN1;SPT16;SPT6;STH1;YTA7,30,153.91368308784527,0.001,0.156,0.908,1.0
33,DNA strand elongation,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16,131.9176003468815,0.001,0.1404,0.996,1.0
33,DNA strand elongation involved in DNA replication,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16,131.9176003468815,0.001,0.1404,0.996,1.0
33,DNA topological change,HMO1;RFA1;RFA2;RFA3;TOP2,5,122.29277559936975,0.004,0.3744,0.988,1.0
33,base-excision repair,APN1;POL2;STH1,3,120.0,0.001,0.156,0.992,1.0
33,chromatin remodeling at centromere,SFH1;STH1;TOP2,3,120.0,0.001,0.156,0.996,1.0
33,double-strand break repair via nonhomologous end joining,CDC28;IRC20;POL2;RSC1;RSC2;RSC30;RSC8;SIN3;SIR2;SIR3,10,120.0,0.001,0.156,0.956,1.0
33,nucleosome disassembly,ARP7;ARP9;ASF1;HTL1;LDB7;NAP1;NPL6;RSC1;RSC2;RSC3;RSC30;RSC4;RSC58;RSC6;RSC8;RSC9;RTT102;SFH1;STH1;YTA7,20,120.0,0.001,0.156,0.928,1.0
33,protein-DNA complex disassembly,ARP7;ARP9;ASF1;HTL1;LDB7;NAP1;NPL6;RSC1;RSC2;RSC3;RSC30;RSC4;RSC58;RSC6;RSC8;RSC9;RTT102;SFH1;STH1;YTA7,20,120.0,0.001,0.156,0.928,1.0
33,mismatch repair,HSM3;MSH3;RFC1;RFC2;RFC3,5,107.44251287059575,0.004,0.3744,0.984,1.0
33,leading strand elongation,DPB4;POL1;POL2;RFC1;RFC2;RFC3;RFC4;RFC5,8,94.83275015809501,0.001,0.1755,0.968,1.0
33,global genome nucleotide-excision repair,HHT1;HHT2;PAF1;RTF1,4,83.87640052032225,0.008,0.702,0.992,1.0
33,copper ion homeostasis,CCC2;HAA1;HHT1;HHT2;SOD1;TMN2,6,76.83275015809501,0.012,0.8022857142857143,0.98,1.0
33,intracellular copper ion homeostasis,HAA1;HHT1;HHT2;SOD1;TMN2,5,76.83275015809501,0.012,0.8022857142857143,0.984,1.0
33,negative regulation of nucleocytoplasmic transport,ISW1;SCS2,2,54.26189294055255,0.044,1.0,0.988,1.0
35,regulation of proteolysis,BLM10;MND2;PBI2;PHB1;PHB2;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,12,201.13623068942698,0.001,0.07389473684210526,1.0,1.0
35,proteasomal ubiquitin-independent protein catabolic process,BLM10;PRE1;PRE10;PRE2;PRE3;PRE4;PRE5;PRE6;PRE7;PRE8;PRE9;PUP1;PUP2;PUP3;SCL1;SSE1;SSE2,17,135.0,0.001,0.07389473684210526,1.0,1.0
35,positive regulation of protein catabolic process,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6,125.28736878557137,0.001,0.07389473684210526,1.0,1.0
35,positive regulation of proteolysis,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6,125.28736878557137,0.001,0.07389473684210526,1.0,1.0
35,positive regulation of proteolysis involved in protein catabolic process,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6,125.28736878557137,0.001,0.07389473684210526,1.0,1.0
35,proteasome regulatory particle assembly,HSM3;NAS6;RPN14;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,9,121.45365019512084,0.001,0.07389473684210526,1.0,1.0
35,proteasome core complex assembly,PRE2;PRE9,2,108.0,0.001,0.07389473684210526,0.988,1.0
35,protein deneddylation,RPN5;RRI2,2,108.0,0.001,0.07389473684210526,0.996,1.0
35,regulation of protein catabolic process,BLM10;MND2;RPN1;RPN2;RPN3;RPT1;RPT2;RPT3;RPT4;RPT5;RPT6;UBP6,12,108.0,0.001,0.07389473684210526,1.0,1.0
35,peptide catabolic process,APE2;RPT2,2,50.32584031219335,0.04,1.0,0.996,1.0
36,regulation of DNA-templated transcription initiation,CHD1;CTR9;DCP2;ISW1;MOT1;POB3;RPT1;RPT3;RPT4;RPT5;RPT6;SGF73;SPT16;SPT6;TAF6;XRN1,16,298.5921480691376,0.008,1.0,1.0,1.0
36,regulation of transcription initiation by RNA polymerase II,CHD1;CTR9;DCP2;ISW1;MOT1;POB3;RPT1;RPT3;RPT4;RPT5;RPT6;SGF73;SPT16;SPT6;XRN1,15,290.46433818621006,0.016,1.0,0.992,1.0
36,regulation of RNA polymerase II transcription preinitiation complex assembly,MOT1;POB3;RPT1;RPT3;RPT4;RPT5;RPT6;SGF73;SPT16,9,256.7400505483367,0.008,1.0,1.0,1.0
36,positive regulation of DNA-templated transcription initiation,DCP2;POB3;RPT1;RPT3;RPT4;RPT5;RPT6;SGF73;SPT16;TAF6;XRN1,11,238.13870525912208,0.012,1.0,1.0,1.0
36,SAGA complex localization to transcription regulatory region,SEM1;SGF29,2,95.70740644616428,0.024,1.0,1.0,1.0
39,aminophospholipid transport,DNF1;DNF2;DRS2;LEM3;MMM1,5,45.0,0.001,0.156,1.0,1.0
39,ceramide transport,DNF1;DNF2;NVJ2;OSH3,4,45.0,0.001,0.156,1.0,1.0
39,lipid translocation,DNF1;DNF2;DRS2;LEM3;YPK1,5,45.0,0.001,0.156,1.0,1.0
39,phospholipid translocation,DNF1;DNF2;DRS2;LEM3;YPK1,5,45.0,0.001,0.156,1.0,1.0
39,phospholipid transport,DNF1;DNF2;DRS2;LEM3;MDM10;MMM1;NVJ2;PDR16;YPK1,9,45.0,0.001,0.156,1.0,1.0
39,regulation of membrane lipid distribution,DNF1;DNF2;DRS2;LEM3;YPK1,5,45.0,0.001,0.156,1.0,1.0
39,amino acid import across plasma membrane,GNP1;MUP3,2,31.453650195120844,0.008,0.8640000000000001,1.0,1.0
39,L-alpha-amino acid transmembrane transport,AVT3;GNP1;MUP3;QDR2;TAT1,5,28.812281309285627,0.012,1.0,1.0,1.0
39,endoplasmic reticulum tubular network organization,PER33;RTN1;RTN2;YOP1,4,22.42275032520141,0.032,1.0,0.996,1.0
39,iron import into cell,AIM14;ENB1;SIT1,3,22.42275032520141,0.032,1.0,0.996,1.0
39,amino sugar biosynthetic process,BCH1;BMH1;BMH2;CHS3,4,21.655462488490688,0.036,1.0,1.0,1.0
39,cell wall chitin biosynthetic process,BCH1;BMH1;BMH2;CHS3,4,21.655462488490688,0.036,1.0,1.0,1.0
39,fungal-type cell wall chitin biosynthetic process,BCH1;BMH1;BMH2;CHS3,4,21.655462488490688,0.036,1.0,1.0,1.0
39,glucosamine-containing compound biosynthetic process,BCH1;BMH1;BMH2;CHS3,4,21.655462488490688,0.036,1.0,1.0,1.0
39,regulation of conjugation with cellular fusion,AKR1;CDC24;MDG1;PRR1;SCP160,5,20.969100130080562,0.04,1.0,0.996,1.0
39,signal transduction involved in positive regulation of conjugation with cellular fusion,AKR1;CDC24;MDG1;SCP160,4,20.969100130080562,0.04,1.0,0.996,1.0
40,vesicle fusion with Golgi apparatus,BOS1;HRR25;SEC17;SEC18;SEC22;SLY1;YIP1,7,126.0,0.001,0.10028571428571428,1.0,1.0
40,N-glycan processing,KTR3;MNN1,2,120.0,0.001,0.10028571428571428,0.992,1.0
40,intracellular manganese ion homeostasis,GDT1;PMR1;SMF3;SPF1,4,120.0,0.001,0.10028571428571428,0.996,1.0
40,maintenance of protein localization in endoplasmic reticulum,EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;RER1,7,120.0,0.001,0.10028571428571428,0.992,1.0
40,manganese ion transport,GDT1;PMR1;SMF3,3,120.0,0.001,0.10028571428571428,0.996,1.0
42,lipoprotein biosynthetic process,AKR1;CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,7,155.34820985270713,0.001,0.03265116279069768,0.992,1.0
42,sphingolipid biosynthetic process,AUR1;ELO3;FLC1;FLC2;IFA38;LAC1;LAG1;LCB1;LCB2;LCB5;LIP1;NPR1;SEI1;TIM54;YPK1,15,141.29073003902417,0.001,0.03265116279069768,1.0,1.0
42,"post-translational protein targeting to membrane, translocation",KAR2;LHS1;SEC61;SEC62;SEC63;SEC66;SPC2;SSH1;STE24,9,140.38764005203222,0.001,0.03265116279069768,1.0,1.0
42,post-translational protein targeting to endoplasmic reticulum membrane,KAR2;LHS1;MDY2;SEC61;SEC62;SEC63;SEC66;SGT2;SPC2;SSH1;STE24,11,140.09691001300806,0.001,0.03265116279069768,1.0,1.0
42,GPI anchor biosynthetic process,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6,135.0,0.001,0.03265116279069768,0.992,1.0
42,GPI anchor metabolic process,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6,135.0,0.001,0.03265116279069768,0.992,1.0
42,ceramide biosynthetic process,LAC1;LAG1;LCB1;LCB2;LIP1,5,135.0,0.001,0.03265116279069768,0.996,1.0
42,ceramide metabolic process,LAC1;LAG1;LCB1;LCB2;LIP1,5,135.0,0.001,0.03265116279069768,0.996,1.0
42,coenzyme A metabolic process,CAB3;HMG1;HMG2;SIS2,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,glycolipid biosynthetic process,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6,135.0,0.001,0.03265116279069768,0.992,1.0
42,isoprenoid biosynthetic process,HMG1;HMG2,2,135.0,0.001,0.03265116279069768,1.0,1.0
42,isoprenoid metabolic process,ALG9;DPM1;HMG1;HMG2;OST1,5,135.0,0.001,0.03265116279069768,0.996,1.0
42,liposaccharide metabolic process,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6,135.0,0.001,0.03265116279069768,0.992,1.0
42,negative regulation of establishment of protein localization,SCS2;SPC2;STE24,3,135.0,0.001,0.03265116279069768,0.996,1.0
42,negative regulation of intracellular transport,ISW1;SCS2;SPC2;STE24,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,"negative regulation of post-translational protein targeting to membrane, translocation",SPC2;STE24,2,135.0,0.001,0.03265116279069768,1.0,1.0
42,negative regulation of protein localization,SCS2;SPC2;STE24,3,135.0,0.001,0.03265116279069768,0.996,1.0
42,negative regulation of transmembrane transport,SPC2;STE24,2,135.0,0.001,0.03265116279069768,1.0,1.0
42,oligosaccharide-lipid intermediate biosynthetic process,ALG2;ALG9;DPM1;OST1,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,protein N-linked glycosylation via asparagine,OST1;OST6;STT3;WBP1,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,protein O-linked mannosylation,BFR1;DPM1;PMT1;PMT2;PMT4,5,135.0,0.001,0.03265116279069768,0.996,1.0
42,protein mannosylation,BFR1;DPM1;MNN5;PMT1;PMT2;PMT4,6,135.0,0.001,0.03265116279069768,0.996,1.0
42,regulation of intracellular protein transport,POR1;SCS2;SPC2;STE24,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,sphingoid metabolic process,LCB1;LCB2;LCB5;TIM54,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,sphingosine biosynthetic process,LCB1;LCB2;LCB5;TIM54,4,135.0,0.001,0.03265116279069768,0.996,1.0
42,protein localization to endoplasmic reticulum exit site,SEC16;YET1;YET3,3,107.90730039024169,0.004,0.11011764705882353,1.0,1.0
42,regulation of transmembrane transport,PHO87;PHO90;PHO91;RGC1;SAP185;SKS1;SPC2;STE24,8,107.90730039024169,0.004,0.11011764705882353,0.996,1.0
42,diol biosynthetic process,FOL2;LCB1;LCB2;LCB5;MCO14;TIM54,6,94.36095058536253,0.008,0.2119245283018868,0.992,1.0
42,polyol biosynthetic process,FOL2;GPP1;LCB1;LCB2;LCB5;MCO14;TIM54,7,94.36095058536253,0.008,0.2119245283018868,0.992,1.0
42,fatty acid biosynthetic process,ACP1;ELO3;ETR1;FAS1;IFA38;OLE1;TSC13,7,91.82448397988911,0.012,0.3063272727272728,0.996,1.0
42,negative regulation of transport,AKL1;ISW1;NPR1;SCS2;SEC6;SPC2;STE24;YPK1,8,76.45365019512084,0.02,0.4841379310344828,0.988,1.0
42,fatty acid elongation,ELO3;IFA38,2,68.34414431809856,0.001,1.0,1.0,1.0
42,tyrosine transport,AVT3;TAT1,2,62.90730039024169,0.04,0.8914285714285715,0.996,1.0
43,"termination of RNA polymerase II transcription, exosome-dependent",PCF11;PTI1;SSU72,3,33.0,0.001,0.12763636363636363,1.0,1.0
43,"termination of RNA polymerase II transcription, poly(A)-coupled",NPL3;PCF11;PTA1;RAI1;REF2;SSU72,6,33.0,0.001,0.12763636363636363,1.0,1.0
43,regulation of protein localization to cell division site involved in cytokinesis,GLC7;REF2,2,18.688670047696206,0.02,1.0,1.0,1.0
43,sno(s)RNA transcription,CTR9;PAF1;RTF1;SSU72,4,18.688670047696206,0.02,1.0,1.0,1.0
43,regulation of protein localization to cell division site,GIN4;GLC7;NBA1;REF2,4,16.443350238481035,0.032,1.0,1.0,1.0
44,tRNA threonylcarbamoyladenosine modification,BUD32;KAE1,2,14.678370091056394,0.008,1.0,1.0,1.0
44,tRNA threonylcarbamoyladenosine metabolic process,BUD32;KAE1;NFS1,3,11.892790030352131,0.02,1.0,1.0,1.0
45,tRNA 5'-leader removal,POP1;POP4;POP5;POP7;PSP2;RPM2,6,25.193820026016112,0.001,0.46799999999999997,1.0,1.0
45,tRNA 5'-end processing,GEP5;POP1;POP4;POP5;POP7;PSP2;RPM2;RRG1;RRG8,9,24.397940008672037,0.001,0.46799999999999997,1.0,1.0
45,box C/D RNA metabolic process,NOP1;POP1;POP3;POP4;POP5;POP6;POP7;POP8;PXR1;RPP1;RPR2,11,21.0,0.001,0.46799999999999997,0.984,1.0
45,plasmid maintenance,KIP1;SNM1,2,16.785580060704262,0.004,1.0,0.992,1.0
45,plasmid partitioning,KIP1;SNM1,2,16.785580060704262,0.004,1.0,0.992,1.0
45,"nuclear-transcribed mRNA catabolic process, RNase MRP-dependent",POP1;POP3;POP4;POP5;POP6;POP7;POP8;RMP1;RPP1,9,10.463950151760658,0.032,1.0,0.992,1.0
46,MAPK cascade,AHK1;HOG1;HOS2;PBS2;SIF2;SNT1,6,60.0,0.001,0.07389473684210526,1.0,1.0
46,nucleus localization,ARP1;CIK1;DYN2;TUB1;TUB3,5,60.0,0.001,0.07389473684210526,1.0,1.0
46,positive regulation of MAPK cascade,AHK1;HOS2;PBS2;SIF2;SNT1,5,60.0,0.001,0.07389473684210526,1.0,1.0
46,positive regulation of stress-activated protein kinase signaling cascade,HOS2;SIF2;SNT1,3,60.0,0.001,0.07389473684210526,1.0,1.0
46,regulation of MAPK cascade,AHK1;HOS2;PBS2;SIF2;SNT1,5,60.0,0.001,0.07389473684210526,1.0,1.0
46,regulation of stress-activated protein kinase signaling cascade,HOS2;SIF2;SNT1,3,60.0,0.001,0.07389473684210526,1.0,1.0
46,stress-activated protein kinase signaling cascade,HOG1;HOS2;PBS2;SIF2;SNT1,5,60.0,0.001,0.07389473684210526,1.0,1.0
46,nuclear migration by microtubule mediated pushing forces,TUB1;TUB3,2,29.897000433601878,0.032,1.0,1.0,1.0
47,spliceosomal conformational changes to generate catalytic conformation,BRR2;CDC40;CEF1;IST3;ISY1;PRP16;PRP19;PRP2;PRP38;PRP4;PRP45;PRP8;SLU7;SNU114;SPP381;SYF1;YJU2,17,180.0,0.001,0.1755,1.0,1.0
47,"mRNA cis splicing, via spliceosome",CBC2;CLF1;CWC15;PRP21;PRP39;PRP40;PRP42;PRP8;PRP9;SNU66;YHC1,11,171.71873254973036,0.001,0.1755,1.0,1.0
47,generation of catalytic spliceosome for second transesterification step,CDC40;CEF1;ISY1;PRP16;PRP45;PRP8;SLU7;YJU2,8,162.0,0.001,0.1755,0.972,1.0
47,mRNA splice site recognition,CDC40;ISY1;LUC7;NAM8;PRP39;PRP42;PRP8;PRP9;YHC1,9,162.0,0.001,0.1755,0.98,1.0
47,spliceosomal complex assembly,CDC40;CLF1;CUS1;EXO84;HSH155;IST3;ISY1;LUC7;NAM8;PRP11;PRP39;PRP42;PRP8;PRP9;RDS3;RSE1;SPT5;YHC1,18,162.0,0.001,0.1755,0.916,1.0
47,generation of catalytic spliceosome for first transesterification step,IST3;PRP19;PRP2;SNU114;SPP381;SYF1;YJU2,7,140.44511010606277,0.001,0.20057142857142857,0.996,1.0
47,mRNA 3'-splice site recognition,CDC40;ISY1;PRP8,3,121.47957512241794,0.001,0.20057142857142857,0.996,1.0
49,polyphosphate biosynthetic process,VTC1;VTC4;VTC5,3,102.0,0.001,0.0936,1.0,1.0
49,polyphosphate metabolic process,PHO87;PHO90;PHO91;VPH1;VTC1;VTC2;VTC3;VTC4;VTC5,9,102.0,0.001,0.0936,1.0,1.0
49,potassium ion transmembrane transport,QDR2;SAP185;VCX1;VNX1;YVC1,5,102.0,0.001,0.0936,1.0,1.0
49,potassium ion transport,QDR2;SAP185;VCX1;VNX1;YVC1,5,102.0,0.001,0.0936,1.0,1.0
49,sodium ion transmembrane transport,VNX1;YVC1,2,102.0,0.001,0.0936,1.0,1.0
49,phosphate ion transmembrane transport,MIR1;PHO87;PHO90;PHO91;SYG1,5,81.52996029484927,0.004,0.3303529411764706,1.0,1.0
49,cellular response to phosphate starvation,PHM8;SYG1,2,49.085714973912225,0.036,1.0,1.0,1.0
49,basic amino acid transmembrane import into vacuole,VSB1;YPQ2,2,44.83779792923003,0.048,1.0,1.0,1.0
49,cellular hyperosmotic response,GPD1;PBS2;VPH1,3,44.83779792923003,0.048,1.0,1.0,1.0
50,cellular bud neck septin ring organization,CDC11;SHS1,2,21.0,0.001,0.0936,1.0,1.0
50,septin ring assembly,BNI5;CBF2;CDC10;CDC12;CDC3;GIN4;SHS1;SKP1,8,21.0,0.001,0.0936,1.0,1.0
50,endoplasmic reticulum polarization,SCS2;SHS1,2,14.678370091056394,0.008,0.702,1.0,1.0
50,maintenance of cell polarity,CDC12;OSH3;PXL1,3,13.445731277666626,0.012,0.936,1.0,1.0
50,cellular bud site selection,BUD31;BUD32;BUD4;CDC24;CHS5;ERV14;MYO3;MYO5;NBA1;PAN1;VRP1,11,11.892790030352131,0.02,1.0,1.0,1.0
52,protein localization to nuclear envelope,MLP1;NUP145;NUP157;NUP170;NUP57,5,22.795880017344075,0.001,0.11699999999999999,1.0,1.0
52,protein localization to nuclear inner membrane,NUP145;NUP157;NUP170;NUP57,4,22.795880017344075,0.001,0.11699999999999999,1.0,1.0
52,nuclear pore localization,NUP120;NUP133;NUP145;NUP84;NUP85;SEC13,6,18.0,0.001,0.11699999999999999,0.996,1.0
52,nuclear pore organization,DYN2;KAP95;NDC1;NIC96;NUP157;NUP170;NUP188;NUP53;NUP57;POM152;POM34;RTN1;SNL1;YOP1,14,18.0,0.001,0.11699999999999999,0.992,1.0
52,nuclear pore complex assembly,DYN2;KAP95;NUP157;NUP170;RTN1;YOP1,6,15.571160121408525,0.004,1.0,1.0,1.0
53,cellular response to nitrogen compound,DAL82;KOG1;YPK1,3,26.891462555333252,0.012,1.0,1.0,1.0
53,cellular response to organonitrogen compound,DAL82;KOG1,2,26.891462555333252,0.012,1.0,1.0,1.0
53,regulation of IRE1-mediated unfolded protein response,ISW1;KIN2,2,26.891462555333252,0.012,1.0,1.0,1.0
53,premeiotic DNA replication,LGE1;POL1,2,25.142320242817053,0.016,1.0,1.0,1.0
53,IRE1-mediated unfolded protein response,IRE1;ISW1;KIN2;SPT20,4,23.785580060704262,0.02,1.0,1.0,1.0
53,establishment or maintenance of actin cytoskeleton polarity,CBK1;MLF3,2,23.785580060704262,0.02,1.0,1.0,1.0
53,establishment or maintenance of cytoskeleton polarity,CBK1;MLF3,2,23.785580060704262,0.02,1.0,1.0,1.0
53,negative regulation of lipid biosynthetic process,GTS1;MOT3;SEI1;YPK1,4,22.677042616037514,0.024,1.0,1.0,1.0
53,negative regulation of lipid metabolic process,GTS1;MOT3;SEI1;YPK1,4,22.677042616037514,0.024,1.0,1.0,1.0
53,regulation of lipid biosynthetic process,GTS1;MOT3;NPR1;NTE1;SEI1;YPK1,6,20.927900303521316,0.032,1.0,1.0,1.0
53,budding cell apical bud growth,BNI1;BOI1;CBK1;CDC28;TAO3,5,19.571160121408525,0.04,1.0,1.0,1.0
53,cellular response to acid chemical,KOG1;NTH1;TPS1;YNL190W,4,19.571160121408525,0.04,1.0,1.0,1.0
53,response to acid chemical,KOG1;NTH1;TPS1;YNL190W,4,19.571160121408525,0.04,1.0,1.0,1.0
54,positive regulation of transcription by galactose,SRB8;SSN2;SSN3;SSN8,4,63.0,0.001,0.20057142857142857,1.0,1.0
54,positive regulation of transcription from RNA polymerase II promoter by galactose,SSN2;SSN3,2,63.0,0.001,0.20057142857142857,1.0,1.0
54,establishment of protein localization to chromosome,GAL11;SIN4,2,34.01556392405627,0.024,1.0,1.0,1.0
54,gene conversion,POL2;SOH1,2,34.01556392405627,0.024,1.0,1.0,1.0
54,regulation of establishment of protein localization to chromosome,GAL11;SIN4,2,34.01556392405627,0.024,1.0,1.0,1.0
54,regulation of ribosomal protein gene transcription by RNA polymerase II,HMO1;HOT1;IFH1;SRB2,4,31.391850455281972,0.032,1.0,1.0,1.0
55,negative regulation of rDNA heterochromatin formation,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8,33.0,0.001,0.05014285714285714,1.0,1.0
55,rDNA chromatin condensation,HMO1;RPD3;SIN3;SMC4;TOF2;YCG1,6,33.0,0.001,0.05014285714285714,1.0,1.0
55,regulation of rDNA heterochromatin formation,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8,33.0,0.001,0.05014285714285714,1.0,1.0
55,negative regulation of G1/S transition of mitotic cell cycle,ASH1;BRE1,2,23.06601014308862,0.008,0.351,1.0,1.0
55,negative regulation of reciprocal meiotic recombination,RPD3;SET2,2,19.75468019078483,0.016,0.6418285714285714,1.0,1.0
55,regulation of reciprocal meiotic recombination,RPD3;SET2;SWI6,3,18.688670047696206,0.02,0.78,1.0,1.0
56,regulation of nitrogen utilization,DAL82;URE2;VID30,3,10.193820026016112,0.02,1.0,1.0,1.0
56,intracellular nitrogen homeostasis,ADY2;ATO2;DAL82;URE2;VID30,5,9.317051811946685,0.028,1.0,1.0,1.0
57,negative regulation of antisense RNA transcription,EAF3;ISW2;RCO1;SET2,4,16.19788758288394,0.024,1.0,1.0,1.0
57,regulation of antisense RNA transcription,EAF3;ISW2;RCO1;SET2,4,16.19788758288394,0.024,1.0,1.0,1.0
57,regulation of ncRNA transcription,EAF3;ISW2;RCO1;SET2,4,16.19788758288394,0.024,1.0,1.0,1.0
57,antisense RNA metabolic process,EAF3;ISW2;RCO1;RRP6;SET2,5,15.528419686577807,0.028,1.0,1.0,1.0
58,cellular response to nitrogen starvation,CCL1;KIN28,2,18.0,0.001,0.23399999999999999,1.0,1.0
58,positive regulation of Atg1/ULK1 kinase complex assembly,CCL1;KIN28,2,18.0,0.001,0.23399999999999999,1.0,1.0
58,regulation of mitotic recombination,HST1;RAD3;SSL2;TOP2,4,18.0,0.001,0.23399999999999999,1.0,1.0
58,positive regulation of DNA recombination,BDF1;CDC28;RAD3;SWI6,4,11.524912523714251,0.012,1.0,1.0,1.0
58,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,CDC73;KIN28;RPB4;RTF1,4,10.775280104064452,0.016,1.0,1.0,1.0
59,positive regulation of metaphase/anaphase transition of cell cycle,APC11;APC5;CDC16;CDC23;MND2,5,36.0,0.001,0.10800000000000001,1.0,1.0
59,positive regulation of nuclear division,APC11;APC5;CDC16;CDC23;CPR1;MND2;SWI6,7,36.0,0.001,0.10800000000000001,1.0,1.0
59,protein K11-linked ubiquitination,APC1;APC2;APC4;APC5;DOC1,5,36.0,0.001,0.10800000000000001,1.0,1.0
59,anaphase-promoting complex-dependent catabolic process,APC1;APC11;APC2;APC4;APC5;CDC16;CDC23;CDC26;CDC27;DOC1;MND2,11,28.77528010406445,0.004,0.3744,1.0,1.0
59,negative regulation of proteasomal protein catabolic process,MND2;UBP6,2,23.049825047428502,0.012,0.8867368421052632,1.0,1.0
59,negative regulation of proteolysis involved in protein catabolic process,MND2;UBP6,2,23.049825047428502,0.012,0.8867368421052632,1.0,1.0
59,regulation of mitotic cell cycle spindle assembly checkpoint,CDC55;MND2,2,21.550560208128903,0.016,1.0,1.0,1.0
59,positive regulation of chromosome organization,HSP82;MND2;RFA1;SBA1,4,16.27856788216575,0.044,1.0,1.0,1.0
60,meiotic DNA double-strand break formation,BRE1;MCM21;RTF1;SET1;SPP1;SWD3;YCG1,7,18.0,0.001,0.702,1.0,1.0
60,regulation of meiotic DNA double-strand break formation,MCM21;SET1;SPP1;SWD3;YCG1,5,18.0,0.001,0.702,1.0,1.0
61,Arp2/3 complex-mediated actin nucleation,ABP1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,16,42.0,0.001,0.06685714285714285,1.0,1.0
61,actin filament polymerization,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;BNI1;CAP1;CAP2;LAS17;PFY1;SLA1;TDA2;TWF1,14,42.0,0.001,0.06685714285714285,1.0,1.0
61,actin nucleation,ABP1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;BNI1;HOF1;LAS17;LSB1;MYO3;MYO5;PAN1;SLA1;SLA2;VRP1,18,42.0,0.001,0.06685714285714285,1.0,1.0
61,actin polymerization or depolymerization,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;BNI1;CAP1;CAP2;COF1;LAS17;PFY1;SLA1;TDA2;TWF1,15,42.0,0.001,0.06685714285714285,1.0,1.0
61,ascospore wall biogenesis,ACT1;ARP2;CHS3;CHS5;END3;GSC2;SWM1;YVH1,8,42.0,0.001,0.06685714285714285,1.0,1.0
61,establishment of mitochondrion localization,AIM21;ARC18;ARP2;MDM10,4,42.0,0.001,0.06685714285714285,1.0,1.0
61,negative regulation of Arp2/3 complex-mediated actin nucleation,LSB1;SLA1;SLA2,3,42.0,0.001,0.06685714285714285,1.0,1.0
61,negative regulation of actin nucleation,HOF1;LSB1;SLA1;SLA2,4,42.0,0.001,0.06685714285714285,1.0,1.0
61,receptor-mediated endocytosis,AKL1;ARC35;CHC1;CMD1;GLC7;HRR25;MYO5;ROD1,8,42.0,0.001,0.06685714285714285,1.0,1.0
61,regulation of actin filament organization,ABP1;AIM21;ARC15;ARC18;ARC40;BNI1;CAP1;CAP2;EFB1;HOF1;LAS17;LSB1;MYO3;MYO5;PAN1;PFY1;SLA1;SLA2;TDA2;TWF1;VRP1,21,42.0,0.001,0.06685714285714285,1.0,1.0
61,actin cortical patch organization,ABP1;AKL1;ARC15;ARC18;ARC19;ARC35;ARC40;ARP2;ARP3;END3;ENT1;ENT2;GID12;PAN1;SLA1;SLA2;SYP1;TWF1,18,29.356740182112787,0.008,0.416,1.0,1.0
61,bipolar cellular bud site selection,MYO3;MYO5;PAN1;VRP1,4,23.785580060704262,0.02,0.9682758620689657,0.996,1.0
61,positive regulation of actin filament bundle assembly,LAS17;PFY1,2,20.927900303521316,0.032,1.0,1.0,1.0
61,regulation of actin filament bundle assembly,EFB1;HOF1;LAS17;PFY1,4,18.991662529193373,0.044,1.0,1.0,1.0
62,negative regulation of TORC1 signaling,IML1;NPR2;NPR3;PBP1,4,18.0,0.001,0.08775,1.0,1.0
62,proline transport,AVT3;NPR2,2,12.581460078048337,0.008,0.624,1.0,1.0
63,"RNA splicing, via transesterification reactions with guanosine as nucleophile",MSS116;NAM2,2,18.872190117072506,0.008,1.0,1.0,1.0
63,mitochondrial transcription,MSS116;RPO41,2,17.287368785571378,0.012,1.0,1.0,1.0
63,negative regulation of translation in response to stress,AAT2;SBP1,2,15.290730039024169,0.02,1.0,1.0,1.0
64,cellular response to oxygen radical,CCS1;MRP1;RSM26;SOD1;SOD2;TRR1,6,96.0,0.001,0.46799999999999997,1.0,1.0
64,cellular response to reactive oxygen species,CCS1;MRP1;RSM26;SOD1;SOD2;TRR1,6,96.0,0.001,0.46799999999999997,1.0,1.0
64,mitochondrial translational initiation,AIM23;IFM1;MRP21;MRP51;RSM28,5,96.0,0.001,0.46799999999999997,1.0,1.0
64,cellular oxidant detoxification,AHP1;CCP1;CCS1;GRX2;GRX7;MRP1;RSM26;SOD1;SOD2;TRR1;TSA1;URE2,12,67.1011204162578,0.008,1.0,1.0,1.0
64,cellular response to toxic substance,AHP1;CCP1;CCS1;GRX2;GRX7;MRP1;OSI1;RSM26;SOD1;SOD2;TRR1;TSA1;URE2,13,57.46816055501041,0.016,1.0,1.0,1.0
64,cellular response to oxygen-containing compound,ASC1;CCS1;GPB2;KOG1;MRP1;NTH1;OSI1;ROD1;RSM26;SOD1;SOD2;TPS1;TRR1;YCK1;YNL190W;YPK1,16,49.690942997048985,0.028,1.0,0.996,1.0
64,mRNA pseudouridine synthesis,CBF5;PUS4,2,49.690942997048985,0.028,1.0,1.0,1.0
64,detoxification,AHP1;CCP1;CCS1;GRX2;GRX7;MRP1;OSI1;PDR15;PDR5;RSM26;SNQ2;SOD1;SOD2;TRR1;TSA1;URE2,16,47.83520069376301,0.032,1.0,1.0,1.0
65,deadenylation-independent decapping of nuclear-transcribed mRNA,CDC36;DCP2;EDC1;MOT2;NOT5;RAI1,6,17.840310032885867,0.008,1.0,0.992,1.0
66,piecemeal microautophagy of the nucleus,ATG13;CDC48;OSH3;TRS85;VAC8;VAM6;VPS33;VPS41,8,17.287368785571378,0.012,1.0,1.0,1.0
67,"retrograde transport, vesicle recycling within Golgi",COG1;COG3;COG4,3,18.0,0.001,0.702,1.0,1.0
